This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Patrys Limited. Active years: 2016-2017.
Location History:
- Mount Waverley, AU (2016)
- Nunawading, AU (2017)
Company Filing History:
Years Active: 2016-2017
Title: Christopher Garth Hosking: Innovator in Antibody Development
Introduction
Christopher Garth Hosking is a notable inventor based in Nunawading, Australia. He has made significant contributions to the field of antibody development, holding 2 patents that focus on innovative methods and compositions for treating various medical conditions.
Latest Patents
His latest patents include "LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same." This invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid, and other compositions. The invention also offers antibodies and functional fragments that bind to the LM-1 antigen, which is useful in treatment and diagnostic methods. One method described involves treating metastasis of a neoplasia, tumor, or cancer in a subject by administering an effective amount of an LM-1 antibody or a functional fragment thereof. Another patent, "PAT-LM1 epitopes and methods for using same," relates to the epitopes of an antibody known as PAT-LM1 and methods for utilizing these epitopes.
Career Highlights
Christopher is associated with Patrys Limited, a company that focuses on developing innovative antibody therapies. His work has been instrumental in advancing the understanding and application of antibodies in medical treatments.
Collaborations
He collaborates with notable colleagues, including Leodevico Luna Ilag and Barbara E Power, who contribute to the research and development efforts at Patrys Limited.
Conclusion
Christopher Garth Hosking's contributions to antibody development highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving treatment options for patients with serious health conditions.